Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Total Non-Current Liabilities (2023 - 2026)

BioAge Labs' Total Non-Current Liabilities history spans 3 years, with the latest figure at $22.5 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 35.72% to $22.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.5 million, a 35.72% decrease, with the full-year FY2025 number at $22.5 million, down 35.72% from a year prior.
  • Total Non-Current Liabilities hit $22.5 million in Q4 2025 for BioAge Labs, down from $27.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BIOA hit a ceiling of $66.4 million in Q4 2023 and a floor of $22.5 million in Q4 2025.
  • Historically, Total Non-Current Liabilities has averaged $33.2 million across 3 years, with a median of $27.5 million in 2025.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 47.34% in 2024 and later grew 19.36% in 2025.
  • Tracing BIOA's Total Non-Current Liabilities over 3 years: stood at $66.4 million in 2023, then tumbled by 47.34% to $35.0 million in 2024, then tumbled by 35.72% to $22.5 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for BIOA at $22.5 million in Q4 2025, $27.5 million in Q3 2025, and $27.3 million in Q2 2025.